CD8A and melanoma: Surprisingly, we observed a higher abundance of terminally exhausted-like TILs in both NSCLCs and melanomas with lower NEOITHS, while enriched activated TILs, effector/memory CD8+ T cell and progenitor CD8+ Tex in tumor with more heterogeneous neoantigens.